Immunovant, Inc.
Immunovant, Inc. (IMVT) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 244 transactions totaling $462.4M, demonstrating a bullish sentiment with $415.0M in net insider flow. The most recent transaction on Dec 18, 2025 involved a sale of 8,529 shares valued at $228.4K.
IMVT Insider Activity Summary
Who Is Buying IMVT Stock?
No significant insider buying has been recorded for IMVT in the recent period.
Who Is Selling IMVT Stock?
No significant insider selling has been recorded for IMVT in the recent period.
Is Immunovant, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IMVT is bullish with an Insider Alignment Score of 95/100 and a net flow of $415.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
IMVT Frequently Asked Questions
Understanding IMVT Insider Activity
Insider trading at Immunovant, Inc. (IMVT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading IMVT stock, having executed 244 transactions in the past 90 days. The most active insider is Sciences Ltd. Roivant (Executive), who has made 10 transactions totaling $977.2M.
Related Tools
Track Immunovant, Inc. Insider Activity
Get notified when executives and directors at IMVT file new Form 4 transactions